Department of Dermatology


close-button

Types of publications

Journal article
Book chapter / Article in edited volumes
Authored book
Translation
Thesis
Edited Volume
Conference contribution
Other publication type
Unpublished / Preprint

Publication year

From
To

Abstract

Journal

Avelumab mediates antibody-dependent cellular cytotoxicity against monocyte-derived dendritic cells through natural killer cells. (2025) Sauerer T, Bremm F, Beenen A, Heger L, Dudziak D, Bosch NC, Erdmann M, et al. Journal article Guidelines for preparation and flow cytometry analysis of human nonlymphoid tissue DC (2025) Dudziak D, Heger L, Agace WW, Bakker J, de Gruijl TD, Dress RJ, Dutertre CA, et al. Journal article Zinc deficiency-associated dermatitis in a prematurely born infant (2025) Grötsch J, Sticherling M Journal article A yet undescribed IRF6 variant causes a new type of ectodermal dysplasia with natal teeth (2025) Peschel N, Willershausen I, Schliep S, Sticherling M, Schneider H Journal article Association Between Local Skin Reactions and Efficacy with 5-Fluorouracil 4% Cream in Actinic Keratosis: A Post-Hoc Analysis of Two Randomised Clinical Trials (2025) Heppt M, Trin K, Mille AC, Groc M, Delarue A, Bégeault N Journal article The Role of Non-coding RNAs in Tumorigenesis, Diagnosis/Prognosis, and Therapeutic Strategies for Cutaneous Melanoma (2025) Schaft N, Dörrie J Journal article, Review article A Network Biology-Guided Investigation of the Long Noncoding RNAs’ Role in Glaucoma (2025) Choudhari JK, Vera J, Chatterjee T Book chapter / Article in edited volumes A Practical Guideline for MicroRNA Sequencing Data Analysis in Chronic Lymphocytic Leukemia (2025) Suomela T, Zhang L, Vera J, Bruns H, Lai X Book chapter / Article in edited volumes Real-world management of patients with complete response under immune-checkpoint inhibition for advanced melanoma (2025) Reitmajer M, Livingstone E, Thoms KM, Heppt M, Meiss F, Gesierich A, Drexler K, et al. Journal article Increased serum NfL and GFAP levels indicate different subtypes of neurologic immune-related adverse events during treatment with immune checkpoint inhibitors (2025) Schmitt C, Müller KJ, Tiedt S, Kramer N, Manger I, Knauss S, Müller-Jensen L, et al. Journal article